Abnormal p53 expression is associated with poor outcomes in grade I or II, stage I, endometrioid carcinoma: a retrospective single-institute study
Journal of Gynecologic Oncology · 2024 · 35 (6)
DOI: 10.3802/jgo.2024.35.e78 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Gynecologic Oncology, 2024. Verfasst von Yu-Wei Chang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics & Gynecology, MacKay Memorial Hospital, Taipei, Taiwan. Hauptthemen laut MEDLINE: Carcinoma, Endometrioid, Endometrial Neoplasms, Tumor Suppressor Protein p53, Neoplasm Staging. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
OBJECTIVE: The Cancer Genome Atlas study revealed an association between copy-number high (p53 abnormal) genetic mutation and poor prognosis in endometrial cancer in 2013. This retrospective study investigated outcomes in patients with abnormal p53 expression and stage I, low-grade endometrial endometrioid carcinoma (EEC). METHODS: We enrolled women with stage I, grade 1 or 2 EEC who received comprehensive staging and adjuvant therapy between January 2019 and December 2022 at MacKay Memorial Hospital, Taipei, Taiwan. Pathologists interpreted immunohistochemistry stains of cancerous tissues to detect p53 mutation. We compared recurrence, survival, progression-free survival, and overall survival between p53 abnormal and p53 normal groups. RESULTS: Of the 115 patients included, 26 had pathologically confirmed abnormal p53 expression. Of these 26 patients, five (19.2%) experienced recurrence, and two died due to disease progression. By contrast, no patients in the normal p53 group experienced disease recurrence or died due to disease progression. Significant intergroup differences were discovered in recurrent disease status (19.4% vs. 0%, p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics & Gynecology, MacKay Memorial Hospital, Taipei, Taiwan.
- Department of Nursing, MacKay Memorial Hospital, Taipei, Taiwan.
- Department of Obstetrics & Gynecology, MacKay Memorial Hospital, Hsinchu Branch, Hsinchu, Taiwan.
- Department of Obstetrics & Gynecology, MacKay Memorial Hospital, Tamsui Branch, New Taipei City, Taiwan.
- Department of General Education, MacKay Junior College of Medicine, Nursing and Management, New Taipei City, Taiwan.
- Department of Medicine, MacKay Medical College, New Taipei City, Taiwan. justyray@mmh.org.tw.
ORCID-Profile: Yu-Wei Chang, Hsiao-Li Kuo, Tzu-Chien Chen, Jessica Chen, Ling Lim, Kung-Liahng Wang, Jen-Ruei Chen
Zitieren
APA
Chang, Y. W., Kuo, H. L., Chen, T. C., Chen, J., Lim, L., Wang, K. L., & Chen, J. R. (2024). Abnormal p53 expression is associated with poor outcomes in grade I or II, stage I, endometrioid carcinoma: a retrospective single-institute study. Journal of Gynecologic Oncology, 35(6). https://doi.org/10.3802/jgo.2024.35.e78
Vancouver
Chang YW, Kuo HL, Chen TC, Chen J, Lim L, Wang KL, et al. Abnormal p53 expression is associated with poor outcomes in grade I or II, stage I, endometrioid carcinoma: a retrospective single-institute study. Journal of Gynecologic Oncology. 2024;35(6). doi:10.3802/jgo.2024.35.e78
BibTeX
@article{Chang2024,
author = {Chang, Yu-Wei and Kuo, Hsiao-Li and Chen, Tzu-Chien and Chen, Jessica and Lim, Ling and Wang, Kung-Liahng and Chen, Jen-Ruei},
title = {Abnormal p53 expression is associated with poor outcomes in grade I or II, stage I, endometrioid carcinoma: a retrospective single-institute study},
journal = {Journal of Gynecologic Oncology},
year = {2024},
volume = {35},
number = {6},
doi = {10.3802/jgo.2024.35.e78}
}
EUVIMED